Argent BioPharma Limited (RGTLF)
OTCMKTS · Delayed Price · Currency is USD
0.0475
0.00 (0.00%)
At close: Feb 6, 2026

Argent BioPharma Statistics

Total Valuation

RGTLF has a market cap or net worth of 3.52 million. The enterprise value is 8.67 million.

Market Cap3.52M
Enterprise Value 8.67M

Important Dates

The next estimated earnings date is Friday, February 27, 2026.

Earnings Date Feb 27, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 84.38M
Shares Outstanding n/a
Shares Change (YoY) +54.47%
Shares Change (QoQ) +25.65%
Owned by Insiders (%) 28.25%
Owned by Institutions (%) 0.96%
Float 35.73M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 29.69
PB Ratio -0.62
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -0.74
EV / Sales 67.67
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -1.42

Financial Position

The company has a current ratio of 0.19

Current Ratio 0.19
Quick Ratio 0.13
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF -0.89
Interest Coverage -304.91

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -147.52%
Return on Invested Capital (ROIC) -549.76%
Return on Capital Employed (ROCE) 187.06%
Weighted Average Cost of Capital (WACC) 2.10%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.03
Inventory Turnover 1.55

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -77.29% in the last 52 weeks. The beta is 0.06, so RGTLF's price volatility has been lower than the market average.

Beta (5Y) 0.06
52-Week Price Change -77.29%
50-Day Moving Average 0.14
200-Day Moving Average 2.56
Relative Strength Index (RSI) 45.98
Average Volume (20 Days) 16,218

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, RGTLF had revenue of 118,380 and -11.70 million in losses. Loss per share was -0.20.

Revenue118,380
Gross Profit -394,046
Operating Income -10.26M
Pretax Income -11.70M
Net Income -11.70M
EBITDA -9.89M
EBIT -10.26M
Loss Per Share -0.20
Full Income Statement

Balance Sheet

The company has 671,609 in cash and 5.43 million in debt, with a net cash position of -4.76 million.

Cash & Cash Equivalents 671,609
Total Debt 5.43M
Net Cash -4.76M
Net Cash Per Share n/a
Equity (Book Value) -5.66M
Book Value Per Share -0.08
Working Capital -5.77M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -6.08 million and capital expenditures -1,463, giving a free cash flow of -6.09 million.

Operating Cash Flow -6.08M
Capital Expenditures -1,463
Free Cash Flow -6.09M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -8,663.31%
Pretax Margin -9,882.48%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

RGTLF does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -54.47%
Shareholder Yield -54.47%
Earnings Yield -332.81%
FCF Yield -173.11%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on October 30, 2023. It was a reverse split with a ratio of 0.001.

Last Split Date Oct 30, 2023
Split Type Reverse
Split Ratio 0.001

Scores

RGTLF has an Altman Z-Score of -108.16 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -108.16
Piotroski F-Score 2